These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19965698)

  • 1. Insufficient evidence to suggest less stringent therapy in hemophilia B?
    den Uijl IE; Roosendaal G; Fischer K
    Blood; 2009 Nov; 114(23):4907; author reply 4907-8. PubMed ID: 19965698
    [No Abstract]   [Full Text] [Related]  

  • 2. Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures.
    Schild FJ; Mauser-Bunschoten EP; Verbout AJ; Van Rinsum AC; Roosendaal G
    J Thromb Haemost; 2009 Oct; 7(10):1741-3. PubMed ID: 19682237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].
    He WW; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):636-8. PubMed ID: 23158747
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.
    Fischer K; Van Der Bom JG; Prejs R; Mauser-Bunschoten EP; Roosendaal G; Grobbee DE; Van Den Berg HM
    Haemophilia; 2001 Nov; 7(6):544-50. PubMed ID: 11851751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis in congenital coagulation disorders: past, present and future.
    Mannucci PM
    Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s1-3. PubMed ID: 19105502
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution.
    Majumdar S; Ostrenga A; Latzman RD; Payne C; Hunt Q; Morris A; Iyer R
    Haemophilia; 2011 Jul; 17(4):717-8. PubMed ID: 21323798
    [No Abstract]   [Full Text] [Related]  

  • 7. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.
    Perry D; Berntorp E; Tait C; Dolan G; Holme PA; Laffan M; Lassila R; Mumford A; Pasi J; Wilde J; Will A; Yee TT
    Haemophilia; 2010 Jan; 16(1):80-9. PubMed ID: 19780845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overall effectiveness of prophylaxis in severe haemophilia.
    Panicker J; Warrier I; Thomas R; Lusher JM
    Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
    Osooli M; Steen Carlsson K; Astermark J; Berntorp E
    Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
    Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current challenges in the management of hemophilia.
    Bauer KA
    Am J Manag Care; 2015 Mar; 21(6 Suppl):S112-22. PubMed ID: 26168206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Knee joint synovectomy as prophylaxis in hemophilic arthropathies].
    Skliarenko ET; Voloshin AI; Sukhoviĭ MV
    Ortop Travmatol Protez; 1991 Jan; (1):35-9. PubMed ID: 2067810
    [No Abstract]   [Full Text] [Related]  

  • 13. Common complications after arthroplasty in patients with haemophilia--a Chinese experience.
    Zhai JL; Weng XS; Peng HM; Sun TW; Zhou L
    Haemophilia; 2015 May; 21(3):e230-e232. PubMed ID: 25649826
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative clotting factor replacement and infection in total knee arthroplasty.
    Wong JM; Mann HA; Goddard NJ
    Haemophilia; 2012 Jul; 18(4):607-12. PubMed ID: 22188657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for randomized trials in hemophilia.
    Mannucci PM
    J Thromb Haemost; 2006 Mar; 4(3):501-2. PubMed ID: 16460428
    [No Abstract]   [Full Text] [Related]  

  • 16. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross sectional study to investigate the influence of treatment regimes on the development of haemophilic arthropathy.
    Hilberg T; Czepa D
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S77-9. PubMed ID: 19763361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders.
    Tagariello G; Iorio A; Santagostino E; Morfini M; Bisson R; Innocenti M; Mancuso ME; Mazzucconi MG; Pasta GL; Radossi P; Rodorigo G; Santoro C; Sartori R; Scaraggi A; Solimeno LP; Mannucci PM;
    Blood; 2009 Jul; 114(4):779-84. PubMed ID: 19357395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All Pharmacokinetics.
    Zhou JY; Barnes RFW; Foster G; Iorio A; Cramer TJ; von Drygalski A
    Clin Appl Thromb Hemost; 2019; 25():1076029619862052. PubMed ID: 31298044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.
    Valentino LA
    Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.